TABLE 4

Radiation Dosimetry Estimates per Unit Administered Activity for 18F-RGD-K5 for Human Adult Male Phantom in 1- and 4.8-Hour Bladder-Voiding Models, Based on Primate Biodistribution Data

Organ1-h void model (μGy/MBq)4.8-h void model (μGy/MBq)
Urinary bladder wall110 ± 65400 ± 100
Upper large intestine wall74 ± 8.377 ± 8.5
Small intestine66 ± 6.869 ± 6.9
Testes44 ± 2.349 ± 2.0
Kidneys38 ± 6.239 ± 6.2
Uterus19 ± 0.337 ± 4.6
Lower large intestine wall29 ± 2.038 ± 2.3
Ovaries18 ± 1.226 ± 1.2
Liver14 ± 2.515 ± 2.4
Gallbladder wall13 ± 1.814 ± 1.7
Spleen11 ± 4.211 ± 4.0
Heart wall11 ± 2.611 ± 2.5
Osteogenic cells8.2 ± 1.79.0 ± 1.4
Stomach wall8.6 ± 1.49.0 ± 1.4
Pancreas8.6 ± 1.68.9 ± 1.6
Muscle6.7 ± 1.08.8 ± 0.4
Red marrow7.1 ± 1.08.5 ± 0.7
Adrenals7.9 ± 1.58.1 ± 1.5
Lungs5.3 ± 1.25.3 ± 1.2
Thymus5.3 ± 1.25.3 ± 1.2
Skin4.3 ± 0.85.1 ± 0.7
Thyroid4.6 ± 1.14.6 ± 1.2
Breast4.2 ± 1.04.2 ± 1.0
Brain1.9 ± 0.61.9 ± 0.6
Total body7.8 ± 1.19.7 ± 0.6
Effective dose (μSv/MBq)23 ± 0.340 ± 4.4
  • Data are mean ± SD; n = 3.